MAPK Pathway and TERT Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients： a Retrospective Study of 2793 Cases

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-0980
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

POT1 and TERT Promoter Molecular Screening in Spanish Melanoma Families

British Journal of Dermatology
DermatologyMedicine
2019English

Study of Ras/Mapk Pathway Gene Variants in Chilean Patients With Cryptorchidism

Andrology
EndocrinologyReproductive MedicineUrologyMetabolismDiabetes
2018English

Gene Expression and Promoter Methylation of Angiogenic and Lymphangiogenic Factors as Prognostic Markers in Melanoma

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Metastases Risk in Thin Cutaneous Melanoma: Prognostic Value of Clinical-Pathologic Characteristics and Mutation Profile

Oncotarget
Oncology
2018English

TERT Promoter Mutations and Polymorphisms as Prognostic Factors in Primary Glioblastoma

Oncotarget
Oncology
2015English

Combined MAPK Pathway and HDAC Inhibition Breaks Melanoma

Cancer Discovery
Oncology
2019English

TERT Promoter Mutations in Ocular Melanoma Distinguish Between Conjunctival and Uveal Tumours

British Journal of Cancer
Cancer ResearchOncology
2013English

Prognostic or Predictive Value of MGMT Promoter Methylation in Gliomas Depends on IDH1 Mutation

Neurology
Neurology
2013English

Erratum To: TERT Promoter Mutation and Telomere Length in Salivary Gland Tumors

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy